Literature DB >> 7681144

Interspecies molecular chimeras of kit help define the binding site of the stem cell factor.

S Lev1, J Blechman, S Nishikawa, D Givol, Y Yarden.   

Abstract

The extracellular portion of the kit-encoded receptor for the stem cell factor (SCF) comprises five immunoglobulin (Ig)-like domains. To localize the ligand recognition site, we exploited the lack of binding of human SCF to the murine receptor by using human-mouse hybrids of Kit and species-specific monoclonal antibodies (MAbs) that inhibit ligand binding. Replacement of the three N-terminal Ig-like domains of the murine Kit with the corresponding portion of the human receptor conferred upon the chimeric receptor high-affinity binding of the human ligand as well as of human-specific ligand-inhibitory MAbs. By constructing five chimeric murine Kit proteins which individually contain each of these three human Ig-like units or pairs of them, we found that the second human domain confers upon the mouse Kit high-affinity binding of the human ligand and also binding of species-specific SCF-competitive MAbs. Nevertheless, the flanking Ig-like domains also affect high-affinity recognition of SCF. Moreover, it appears that the determinants that define ligand specificity of the murine and the human receptors do not structurally coincide. This observation allowed us to identify a chimeric receptor that displayed a dual specificity; namely, it bound with high affinity either the human or the murine SCF molecules and reacted with mouse- as well as human-specific ligand-inhibitory MAbs. Conversely, another chimera, which included all of the five Ig-like domains, bound neither ligand. In conclusion, interdomain packing involving the second Ig-like domain of human Kit and noncontiguous structural motifs of the receptor are involved in SCF recognition.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681144      PMCID: PMC359543          DOI: 10.1128/mcb.13.4.2224-2234.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  35 in total

1.  Transformation of mammalian cells with genes from procaryotes and eucaryotes.

Authors:  M Wigler; R Sweet; G K Sim; B Wold; A Pellicer; E Lacy; T Maniatis; S Silverstein; R Axel
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

2.  The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus.

Authors:  E Huang; K Nocka; D R Beier; T Y Chu; J Buck; H W Lahm; D Wellner; P Leder; P Besmer
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

3.  Identification of a ligand for the c-kit proto-oncogene.

Authors:  D E Williams; J Eisenman; A Baird; C Rauch; K Van Ness; C J March; L S Park; U Martin; D Y Mochizuki; H S Boswell
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

4.  The ligand specificities of the insulin receptor and the insulin-like growth factor I receptor reside in different regions of a common binding site.

Authors:  T Kjeldsen; A S Andersen; F C Wiberg; J S Rasmussen; L Schäffer; P Balschmidt; K B Møller; N P Møller
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

Review 5.  Hereditary anemias of the mouse: a review for geneticists.

Authors:  E S Russell
Journal:  Adv Genet       Date:  1979       Impact factor: 1.944

6.  Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver--conditioned medium.

Authors:  K M Zsebo; J Wypych; I K McNiece; H S Lu; K A Smith; S B Karkare; R K Sachdev; V N Yuschenkoff; N C Birkett; L R Williams
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

7.  Noncontiguous regions in the extracellular domain of EGF receptor define ligand-binding specificity.

Authors:  I Lax; R Fischer; C Ng; J Segre; A Ullrich; D Givol; J Schlessinger
Journal:  Cell Regul       Date:  1991-05

8.  Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities.

Authors:  S Werner; D S Duan; C de Vries; K G Peters; D E Johnson; L T Williams
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

9.  Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene.

Authors:  T Miki; D P Bottaro; T P Fleming; C L Smith; W H Burgess; A M Chan; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

10.  Oncogenic forms of the neu/HER2 tyrosine kinase are permanently coupled to phospholipase C gamma.

Authors:  E Peles; R B Levy; E Or; A Ullrich; Y Yarden
Journal:  EMBO J       Date:  1991-08       Impact factor: 11.598

View more
  13 in total

1.  Structural basis for stem cell factor-KIT signaling and activation of class III receptor tyrosine kinases.

Authors:  Heli Liu; Xiaoyan Chen; Pamela J Focia; Xiaolin He
Journal:  EMBO J       Date:  2007-01-25       Impact factor: 11.598

2.  The N-terminal globular domain of Eph receptors is sufficient for ligand binding and receptor signaling.

Authors:  J P Labrador; R Brambilla; R Klein
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

3.  Design of recombinant stem cell factor-macrophage colony stimulating factor fusion proteins and their biological activity in vitro.

Authors:  Tao Chen; Jie Yang; Yuelang Wang; Chenyang Zhan; Yuhui Zang; Junchuan Qin
Journal:  J Comput Aided Mol Des       Date:  2005-05       Impact factor: 3.686

4.  Neoplasia driven by mutant c-KIT is mediated by intracellular, not plasma membrane, receptor signaling.

Authors:  Zhifu Xiang; Frederike Kreisel; Jennifer Cain; AnnaLynn Colson; Michael H Tomasson
Journal:  Mol Cell Biol       Date:  2006-10-23       Impact factor: 4.272

5.  Neutralization of KIT Oncogenic Signaling in Leukemia with Antibodies Targeting KIT Membrane Proximal Domain 5.

Authors:  Marianne Le Gall; Ronan Crépin; Madeline Neiveyans; Christian Auclair; Yongfeng Fan; Yu Zhou; James D Marks; André Pèlegrin; Marie-Alix Poul
Journal:  Mol Cancer Ther       Date:  2015-09-10       Impact factor: 6.261

6.  C-KIT mutation cooperates with full-length AML1-ETO to induce acute myeloid leukemia in mice.

Authors:  Yue-Ying Wang; Li-Juan Zhao; Chuan-Feng Wu; Ping Liu; Lin Shi; Yang Liang; Shu-Min Xiong; Jian-Qing Mi; Zhu Chen; Ruibao Ren; Sai-Juan Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-24       Impact factor: 11.205

7.  Role of stem cell factor and its receptor in the pathogenesis of pediatric aplastic anemia.

Authors:  Jun Wang; Jianfei Feng; Wei Wang; Yu Hu; Xuelian Zhao; Hong Wang; Shaoxian Zhu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

8.  Structure of the active core of human stem cell factor and analysis of binding to its receptor kit.

Authors:  X Jiang; O Gurel; E A Mendiaz; G W Stearns; C L Clogston; H S Lu; T D Osslund; R S Syed; K E Langley; W A Hendrickson
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

9.  Analysis of stromal cell secretomes reveals a critical role for stromal cell-derived hepatocyte growth factor and fibronectin in angiogenesis.

Authors:  Andrew C Newman; Wayne Chou; Katrina M Welch-Reardon; Ashley H Fong; Stephanie A Popson; Duc Thien Phan; Daniel R Sandoval; Dananh P Nguyen; Paul D Gershon; Christopher C W Hughes
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-03       Impact factor: 8.311

10.  Identification of the ligand-binding regions in the macrophage colony-stimulating factor receptor extracellular domain.

Authors:  Z E Wang; G M Myles; C S Brandt; M N Lioubin; L Rohrschneider
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.